BIOCAD was founded in 2001. It is a leading Russian biotechnology company that carries out full cycle of development, research, and production of drugs for the treatment of oncological, autoimmune, and genetic diseases.
BIOCAD brings together world-class R&D centers, modern pharmaceutical and biotechnological production, and preclinical and clinical trials, compliant with international standards.